Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports dated February 25, 2016, relating to the consolidated financial statements and financial statement schedules of Novelion Therapeutics Inc. (formerly known as QLT Inc.) (the “Company”) and the effectiveness of the Company’s internal control over financial reporting, appearing in the Annual Report on Form 10-K of the Company for the year ended December 31, 2015.

 

/s/ Deloitte LLP

 

Chartered Professional Accountants

 

Vancouver, Canada
December 5, 2016